VistaGen Therapeutics Earnings Preview
Portfolio Pulse from Benzinga Insights
VistaGen Therapeutics (NASDAQ:VTGN) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.68. The company's past performance shows a mix of positive and negative price changes post-earnings release. The stock was trading at $3.475 as of November 07, with a 52-week return of -19.36%.
November 08, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
VistaGen Therapeutics is expected to report an EPS of $-0.68 in its upcoming earnings. The stock's price has seen mixed changes following past earnings releases, and it has a negative 52-week return of -19.36%.
The upcoming earnings report is a significant event for VistaGen Therapeutics. The estimated EPS of $-0.68 will be a key factor for investors. However, the company's past performance shows mixed price changes following earnings releases, indicating that the stock's reaction to earnings can be unpredictable. Additionally, the negative 52-week return suggests a bearish sentiment among long-term shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100